Detection and monitoring of driver mutations by next‐generation sequencing in squamous cell lung cancer patient and possible predictive biomarker of third generation EGFR‐tyrosine kinase inhibitors

Driver mutation detection and the development of targeted drugs have significantly improved survival of advanced lung adenocarcinoma patients with driver mutations. However, we still lack understanding of druggable mutations in patients with advanced squamous cell lung cancer (SQCLC). Less than 10%...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Thorac Cancer
Main Authors: Shen, Xiaoyan, Shen, Jie, Zhang, Hang, Cheng, Yuxin, Yang, Yang, Gao, Jiahui, Zhang, Yu, Li, Rutian, Liu, Baorui, Wang, Lifeng
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons Australia, Ltd 2017
Assuntos:
Case Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5754292/
https://ncbi.nlm.nih.gov/pubmed/29143497
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12551
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados